Examples of using Previously treated in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Inhibitors are an uncommon event in previously treated patients(PTPs) receiving factor IX-containing products.
31% of patients achieved a haematological response 36% in previously untreated patients and 22% in previously treated patients.
You should tell your doctor if you have been previously treated with factor VIII products,
in patients with previously treated ALK-positive advanced NSCLC.
XALKORI is indicated for the treatment of adults with previously treated anaplastic lymphoma kinase(ALK)-positive advanced non-small cell lung cancer NSCLC.
Safety of ReFacto AF was evaluated in previously treated children and adolescents n=18,
31% of patients achieved a haematological response(36% in previously untreated patients and 22% in previously treated patients) Table 2.
determine the safety and efficacy of VELCADE in patients with previously treated light-chain(AL) Amyloidosis.
in patients with previously treated ALK-positive advanced NSCLC.
if you have or have not been previously treated for chronic hepatitis C infection.
The study included both previously treated patients and those who had not received HIV medicines before.
Revlimid has been studied in two main studies involving 704 patients with previously treated multiple myeloma.
Two main studies involving 1,099 previously untreated and 404 previously treated patients with chronic hepatitis C genotype 1 infection and compensated liver disease
Inhibitors have been observed in previously treated patients receiving factor VIII products,
had been previously treated with DMARDs.
May affect up to 1 in 100 users formation of neutralising antibodies to factor VIII(inhibitors) in previously treated patients.
Also, there have been spontaneous post-marketing reports of high-titre inhibitors involving previously treated patients.
concerns not solely the strains isolated from the previously treated, but also from newly diagnosed patients.
A total of 114 patients with previously treated chronic ITP were randomised 2:1 eltrombopag(n=76) to placebo n=38.
All pharmacokinetic studies with ELOCTA were conducted in previously treated patients with severe haemophilia A. Data presented in this section were obtained by chromogenic